Search Within

Matthew J Matasar

  1. "Lymphoma"
  2. "Survivorship Research"
  3. "Miguel-Angel Perales"
  4. "Bone Marrow Transplant"
Formats
  1. Meeting Abstract (10)
  2. Journal Article (8)
Groups
  1. Bone Marrow Transplant (18)
  2. Center for Hematologic Malignancies (18)
  3. Department of Medicine (18)
  4. Hematologic Malignancies, Division of (18)
  5. Lymphoma (18)
  6. Survivorship Research (18)

More Groups

People
  1. Miguel-Angel Perales (18)
  2. Craig Sauter (15)
  3. Craig Moskowitz (12)
  4. Paul Hamlin (11)
  5. Alison Moskowitz (10)
  6. Andrew Zelenetz (10)

More People

Years
  1. 2022 (1)
  2. 2021 (1)
  3. 2020 (1)
  4. 2019 (3)
  5. 2018 (2)
  6. 2017 (2)

More Years

Publications
  1. Blood (7)
  2. Biology of Blood and Marrow Transplantation (4)
  3. Blood Advances (2)
  4. Haematologica (1)
  5. Hematological Oncology (1)
  6. Journal of Clinical Oncology (1)

More Publications

Publishers
  1. American Society of Hematology (9)
  2. Elsevier Inc. (5)
  3. American Society of Clinical Oncology (1)
  4. Elsevier Science, Inc. (1)
  5. Ferrata Storti Foundation (1)
  6. Wiley Blackwell (1)

Results (18)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Utility of routine pulmonary function test after autologous hematopoietic cell transplantation in lymphoma
    Meeting Abstract

    Dahi, P. B.; Geyer, A.; Kenny, S.; Flynn, J.; Devlin, S. M.; Ruiz, J. D.; Lahoud, O. B.; Matasar, M. J.; Moskowitz, C. H.; Perales, M. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Toxicities of high-dose chemotherapy and autologous hematopoietic cell transplantation in older patients with lymphoma
    Journal Article

    Dahi, P. B.; Lee, J.; Devlin, S. M.; Ruiz, J.; Maloy, M.; Rondon-Clavo, C.; Petrlik, E.; Tamari, R.; Shah, G.; Scordo, M.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Outcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapies
    Journal Article

    Sermer, D.; Batlevi, C.; Lia Palomba, M.; Shah, G.; Lin, R. J.; Perales, M. A.; Scordo, M.; Dahi, P.; Pennisi, M.; Afuye, A.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Long-term follow-up confirms durability of single-agent brentuximab vedotin as pre-transplant salvage for classical Hodgkin lymphoma
    Meeting Abstract

    Moskowitz, A. J.; Schoder, H.; Lee, J.; Davey, T.; Hancock, H.; Hamlin, P. A.; Horwitz, S. M.; Kumar, A.; Matasar, M. J.; Noy, A.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Contemporary outcomes in HTLV-1-associated adult T-cell leukemia/lymphoma: Single-institution experience
    Meeting Abstract

    Epstein-Peterson, Z. D.; Ghione, P.; Moskowitz, A. J.; Dahi, P. B.; Dogan, A.; Kumar, A.; Matasar, M. J.; Noy, A.; Perales, M. A.; Ponce, D. M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • CD19 CAR T cells following autologous transplantation in poor-risk relapsed and refractory B-cell non-Hodgkin lymphoma
    Journal Article

    Sauter, C. S.; Senechal, B.; Rivière, I.; Ni, A.; Bernal, Y.; Wang, X.; Purdon, T.; Hall, M.; Singh, A. N.; Szenes, V. Z.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Impact of pre-transplant rituximab on efficacy of revaccination of lymphoma patients after autologous hematopoietic stem cell transplantation
    Meeting Abstract

    Preston, E. V.; Palazzo, M. A.; Seier, K.; Devlin, S. M.; Giralt, S.; Scordo, M.; Dahi, P. B.; Matasar, M. J.; Moskowitz, C. H.; Sauter, C. S.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Transformed indolent lymphoma outcomes similar to de novo diffuse large B-cell lymphoma after autologous hematopoietic stem cell transplantation (AHCT), but not allogeneic HCT (allo-HCT)
    Meeting Abstract

    Pathak, P.; Shah, G. L.; Tsyvkin, E.; Maloy, M.; Knezevic, A.; Devlin, S. M.; Giralt, S. A.; Matasar, M. J.; Moskowitz, C. H.; Sauter, C. S.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Prognostic significance of baseline metabolic tumor volume in relapsed and refractory Hodgkin lymphoma
    Journal Article

    Moskowitz, A. J.; Schöder, H.; Gavane, S.; Thoren, K. L.; Fleisher, M.; Yahalom, J.; McCall, S. J.; Cadzin, B. R.; Fox, S. Y.; Gerecitano, J.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Baseline metabolic tumor volume is an independent prognostic factor for relapsed and refractory Hodgkin lymphoma patients receiving PET-adapted salvage therapy with brentuximab vedotin and augmented ICE
    Meeting Abstract

    Moskowitz, A. J.; Schöder, H.; Gavane, S.; Thoren, K. L.; Fleisher, M.; Yahalom, J.; McCall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save